Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression
- 13 October 2004
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 44 (8), 1609-1618
- https://doi.org/10.1016/j.jacc.2004.07.023
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Progression From Compensated Hypertrophy to Failure in the Pressure-Overloaded Human HeartCirculation, 2003
- Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMPHeart, 2002
- Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive ratsJournal of the American College of Cardiology, 2002
- Matrix metalloproteinases and tissue inhibitors of metalloproteinases in hamster aortic atherosclerosis: correlation with in-situ zymographyAtherosclerosis, 2002
- Regression of Left Ventricular Hypertrophy After Surgical Therapy for Aortic Stenosis Is Associated With Changes in Extracellular Matrix Gene ExpressionCirculation, 2001
- A Matrix Metalloproteinase Induction/Activation System Exists in the Human Left Ventricular Myocardium and Is Upregulated in Heart FailureCirculation, 2000
- Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted ratCardiovascular Research, 2000
- Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory controlAmerican Journal of Physiology-Heart and Circulatory Physiology, 2000
- Differential Expression of Tissue Inhibitors of Metalloproteinases in the Failing Human HeartCirculation, 1998
- Time-Dependent Changes in Matrix Metalloproteinase Activity and Expression During the Progression of Congestive Heart FailureCirculation Research, 1998